| Features: |
| Cysteamine is a prescription drug, approved for treating cystinosis -it is not sold over-the-counter as a dietary supplement. -In contrast, related compounds like N-acetylcysteine (NAC) and pantethine are widely available supplements and can indirectly support cysteamine-related pathways (e.g., antioxidant defenses and CoA metabolism). -Pantethine: Precursor to CoA, which breaks down into cysteamine -Pantothenic Acid (Vitamin B5): Required for CoA synthesis -Cysteamine increases glutathione (GSH) levels, reducing oxidative stress, a major contributor to AD pathology. -Some studies suggest that cysteamine increases brain-derived neurotrophic factor (BDNF) levels -Cysteamine has been observed to reduce amyloid plaque burden in animal models of AD. |
| Source: |
| Type: |
| antioxidant responsive element (ARE) ARE in Normal Cells: Protective Role ARE-regulated genes include NQO1, HO-1, GCLM, GCLC, and various glutathione S-transferases (GSTs). -Detoxify reactive oxygen species (ROS) -Agents like sulforaphane (from broccoli) can activate ARE in healthy cells to prevent cancer initiation. -overactivation in cancer cells aids cancer survival, growth, resistance |
| 4333- | Cyste, | Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription |
| - | vitro+vivo, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:369 Target#:1354 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid